{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.3:c.89C>C",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "C",
            "alt": "C",
            "position": "89"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "c.89C>C (p.Ala30Pro)"
        },
        {
          "HGVS": "NM_000345.3:c.157G>A",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "G",
            "alt": "A",
            "position": "157"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "c.157G>A (p.Ala53Thr)"
        },
        {
          "HGVS": "NM_000345.3:c.157G>A; NM_000345.3:c.89C>C",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "G;C",
            "alt": "A;C",
            "position": "157;89"
          },
          "Protein Change": {
            "ref": "A;A",
            "alt": "T;P",
            "position": "53;30"
          },
          "Description in input context": "c.157G>A; c.89C>C (p.Ala53Thr; p.Ala30Pro)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005337"
  },
  "Experiment Method": [
    {
      "Assay Method": "Circular Dichroism Spectroscopy",
      "Material used": {
        "Material Source": "Recombinant human α-synuclein protein",
        "Material Name": "Recombinant human α-synuclein",
        "Description": "The experiment was conducted using recombinant human α-synuclein protein."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.3:c.89C>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The A30P mutant fails to undergo a typical structural transition from random coil to a-helix."
        },
        {
          "Variant": "NM_000345.3:c.157G>A",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "The A53T mutant shows no significant difference from WT in its secondary structure upon membrane-binding."
        },
        {
          "Variant": "NM_000345.3:c.157G>A; NM_000345.3:c.89C>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The double mutant A53T/A30P is defective in membrane binding, similar to the A30P mutant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "The experiments were repeated several times to confirm their reproducibility."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed multiple times."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Buffer alone was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Standard deviation and mean values were calculated."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Ellipticity at 222 nm greater than 3.3",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Ellipticity at 222 nm less than 3.3",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Ultracentrifugation",
      "Material used": {
        "Material Source": "Brain PE/PS MLVs",
        "Material Name": "Brain PE/PS MLVs",
        "Description": "Brain PE/PS MLVs were used as the lipid source."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.3:c.89C>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Significantly less A30P α-synuclein was found in the membrane fraction."
        },
        {
          "Variant": "NM_000345.3:c.157G>A",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "A53T α-synuclein was found in the membrane fraction similarly to WT."
        },
        {
          "Variant": "NM_000345.3:c.157G>A; NM_000345.3:c.89C>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Double mutant A53T/A30P α-synuclein was defective in membrane binding, similar to the A30P mutant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "The experiments were repeated several times to confirm their reproducibility."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed multiple times."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Buffer alone was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Standard deviation and mean values were calculated."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Significant fraction of α-synuclein in the membrane pellet",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Negligible fraction of α-synuclein in the membrane pellet",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "X-ray Diffraction",
      "Material used": {
        "Material Source": "Brain PE/PS MLVs",
        "Material Name": "Brain PE/PS MLVs",
        "Description": "Brain PE/PS MLVs were used as the lipid source."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.3:c.89C>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "A30P mutant did not significantly alter the pressure versus repeat distance relationship of the pure lipid bilayer."
        },
        {
          "Variant": "NM_000345.3:c.157G>A",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "A53T mutant showed similar behavior to WT α-synuclein in altering the pressure versus repeat distance relationship."
        },
        {
          "Variant": "NM_000345.3:c.157G>A; NM_000345.3:c.89C>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Double mutant A53T/A30P showed similar behavior to A30P mutant in altering the pressure versus repeat distance relationship."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "The experiments were repeated several times to confirm their reproducibility."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed multiple times."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Buffer alone was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Standard deviation and mean values were calculated."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Repeat spacing alteration greater than 10% compared to pure lipid bilayer",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Repeat spacing alteration less than 5% compared to pure lipid bilayer",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}